Covid-19 mRNA vaccine booster outlook positive despite heart inflammation risk
Pfizer drew headlines this month when it raised the idea of an emergency authorization for its COVID-19 mRNA vaccine booster to combat the Delta variant. But what does this mean for its rare heart inflammation side effects?
